These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1851578

  • 1. Radiotherapy plus lonidamine in non-small cell lung cancer.
    Cionini L.
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):49-52. PubMed ID: 1851578
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
    Scarantino CW, McCunniff AJ, Evans G, Young CW, Paggiarino DA.
    Int J Radiat Oncol Biol Phys; 1994 Jul 30; 29(5):999-1004. PubMed ID: 8083102
    [Abstract] [Full Text] [Related]

  • 3. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F.
    Drugs Today (Barc); 2003 Mar 30; 39(3):157-74. PubMed ID: 12730701
    [Abstract] [Full Text] [Related]

  • 4. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U, Cavalli F, Häussinger K, Kaukel E, Koschel G, Martinelli G, Neuhauss R, von Pawel J.
    Semin Oncol; 1991 Apr 30; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V, Cattaneo MT, Rho B, Frontini L, D'Adda D, Isa L, Scapaticci R, Legnani W, Calzavara MP, Berni F.
    Oncology; 1993 Apr 30; 50(1):10-3. PubMed ID: 8380632
    [Abstract] [Full Text] [Related]

  • 6. Clinical study and pharmacokinetics of lonidamine in advanced non-small cell lung cancer.
    Jones AL, Hardy JR, Newell DR, Smith IE.
    Eur J Cancer; 1991 Apr 30; 27(4):519. PubMed ID: 1851622
    [No Abstract] [Full Text] [Related]

  • 7. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
    Scagliotti GV, Gozzelino F, Albera C, Pescetti G.
    Chemotherapy; 1989 Apr 30; 35(1):64-8. PubMed ID: 2541978
    [Abstract] [Full Text] [Related]

  • 8. Lonidamine versus polychemotherapy in advanced non-small-cell lung cancer. A preliminary analysis.
    Giaccone G, Bagatella M, Donadio M, Bonardi G, Maestroni F, Calciati A.
    Tumori; 1989 Feb 28; 75(1):43-6. PubMed ID: 2540581
    [Abstract] [Full Text] [Related]

  • 9. Lonidamine in non-small-cell lung cancer: a phase II study.
    Contu A, Olmeo NA, Pani P, Deriu A, Ortu S, Paga C.
    Tumori; 1991 Feb 28; 77(1):52-5. PubMed ID: 1850177
    [Abstract] [Full Text] [Related]

  • 10. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
    Cakir S, Egehan I.
    Lung Cancer; 2004 Mar 28; 43(3):309-16. PubMed ID: 15165089
    [Abstract] [Full Text] [Related]

  • 11. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Fietkau R.
    Strahlenther Onkol; 2003 Dec 28; 179(12):823-31. PubMed ID: 14652671
    [Abstract] [Full Text] [Related]

  • 12. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G, Ciottoli GB, Patanè C, Palmucci T, Tafuri G, Marletta F, De Luca B, Magnani F, De Gregorio M, Greco S.
    Radiother Oncol; 1987 Dec 28; 10(4):285-90. PubMed ID: 3444905
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics of oral lonidamine in breast and lung cancer patients.
    Newell DR, Mansi J, Hardy J, Button D, Jenns K, Smith IE, Picollo R, Catanese B.
    Semin Oncol; 1991 Apr 28; 18(2 Suppl 4):11-7. PubMed ID: 2031191
    [Abstract] [Full Text] [Related]

  • 14. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
    DeAngelis LM, Currie VE, Kim JH, Krol G, O'Hehir MA, Farag FM, Young CW, Posner JB.
    J Neurooncol; 1989 Sep 28; 7(3):241-7. PubMed ID: 2677257
    [Abstract] [Full Text] [Related]

  • 15. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer.
    Cullen MH.
    Semin Oncol; 1994 Jun 28; 21(3 Suppl 4):34-41. PubMed ID: 8209275
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of lonidamine in non-small cell lung cancer: final report.
    Kokron O, Maca S, De Gregorio M, Ciottoli GB.
    Br J Cancer; 1990 Feb 28; 61(2):316-8. PubMed ID: 2155644
    [Abstract] [Full Text] [Related]

  • 17. [The recent progress in chemoradiotherapy of lung cancer].
    Ogawara M, Kawahara M, Furuse K.
    Gan To Kagaku Ryoho; 1997 Nov 28; 24(14):2058-64. PubMed ID: 9388514
    [Abstract] [Full Text] [Related]

  • 18. Single- and multiple dose pharmacokinetics of lonidamine in patients suffering from non-small-cell lung cancer.
    Gatzemeier U, Toomes H, Picollo R, Christoffel V, Lücker PW, Ulmer J.
    Arzneimittelforschung; 1991 Apr 28; 41(4):436-9. PubMed ID: 1650226
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
    Kokron O, Maca S, Scheiner W, De Gregorio M, Ciottoli GB.
    Oncology; 1984 Apr 28; 41 Suppl 1():86-9. PubMed ID: 6717902
    [Abstract] [Full Text] [Related]

  • 20. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.
    Cancer Prev Control; 1997 Aug 28; 1(3):249-59. PubMed ID: 9765750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.